August 17th, 2021 – Medicinal Genomics Assay Receives AOAC’s First Certification for Cannabis Flower and Infused Edibles – MGC is the first manufacturer to receive certification for cannabis-infused edibles and is also the first to offer AOAC-approved cannabis assays for two different qPCR machines: Agilent AriaMX and BioRad CFX96.

August 17th, 2021 – AOAC Approves Two New Microbiological Assays – The Medicinal Genomics platform can detect four species, including A. flavus, A. fumigatus, A. niger, and A. terreus in both flower and infused edibles. The PathoSEEK microbial testing platform uses a PCR-based assay and provides an internal plant DNA control for every reaction.

July 1, 2021 – Growth Media Used in Total Yeast and Mold Testing Can Significantly Affect Microbial Diversity, Study Finds – The growth media used in plating-based total yeast and mold count (TYMC) tests can dramatically impact the diversity of microbes that grow, according to a new investigation from scientists at Medicinal Genomics, a specialist cannabis testing and genetics screening firm.

May 18th, 2021 – Medicinal Genomics Hires Sherman Hom as New Director of Regulatory Affairs – Medicinal Genomics has hired Sherman Hom, Ph.D. to be their first director of regulatory affairs. Dr. Hom is coming from a position at New Jersey’s Division of Public Health and Environmental Laboratories (PHEL) where he was the leading research scientist for the state’s cannabis testing lab as well as coordinating their pre-analytical activities for SARS-CoV-2 testing.


November 5, 2021 – Hop Latent Viroid. Why the Smallest Cannabis Pathogen is the Biggest Problem-HLVd is most commonly spread via mechanical infection from equipment. Cultivators who prune an infected plant, and then turn around and use the same shears/scissors to work on its neighbor have just spread the infection.

September 1, 2021 -The Major Magic Mushroom Species You Should Know About – Earlier this year, Medicinal Genomics published a highly contiguous reference genome for P. cubensis, which the team hopes will inform more research into the genes of interest and pathways responsible for producing psilocybin.

May 17th, 2021 – Healthcare Provider-Focused Medical Cannabis Research Study Launched by Cannabis Center of Excellence, Medicinal Genomics, and UMass Dartmouth – The Cannabis Center of Excellence, Inc., Medicinal Genomics, and UMass Dartmouth have established the Healthcare Provider Knowledge, Attitudes, Practices Related to Medical Cannabis Research Study to help better understand the experiences of healthcare providers have seen with medical cannabis.

July 30th, 2021 – Medical Cannabis Insights, Part II: How Cannabis Helps Opioid Addiction and A Discussion on Interactions with Other Medications – In this roundtable interview series, we speak to each of the organizers to learn more about them and what attends can expect from the practicum. Here in part II, they discuss how cannabis can be used stop opioid addiction and possible ways cannabis might interact with other prescription medications.